279 related articles for article (PubMed ID: 28819100)
1. Blockage of the lysosome-dependent autophagic pathway contributes to complement membrane attack complex-induced podocyte injury in idiopathic membranous nephropathy.
Liu WJ; Li ZH; Chen XC; Zhao XL; Zhong Z; Yang C; Wu HL; An N; Li WY; Liu HF
Sci Rep; 2017 Aug; 7(1):8643. PubMed ID: 28819100
[TBL] [Abstract][Full Text] [Related]
2. Klotho Stabilizes the Podocyte Actin Cytoskeleton in Idiopathic Membranous Nephropathy through Regulating the TRPC6/CatL Pathway.
Wang H; Liu H; Cheng H; Xue X; Ge Y; Wang X; Yuan J
Am J Nephrol; 2024; 55(3):345-360. PubMed ID: 38330925
[TBL] [Abstract][Full Text] [Related]
3. Lysosome restoration to activate podocyte autophagy: a new therapeutic strategy for diabetic kidney disease.
Liu WJ; Gan Y; Huang WF; Wu HL; Zhang XQ; Zheng HJ; Liu HF
Cell Death Dis; 2019 Oct; 10(11):806. PubMed ID: 31649253
[TBL] [Abstract][Full Text] [Related]
4. Association of podocyte autophagosome numbers with idiopathic membranous nephropathy and secondary membranous nephropathy.
Jin J; Zhan H; Lin B; Li Y; Zhang W; He Q
Int Urol Nephrol; 2017 Jun; 49(6):1025-1031. PubMed ID: 28285376
[TBL] [Abstract][Full Text] [Related]
5. Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro.
Chen ZH; Qin WS; Zeng CH; Zheng CX; Hong YM; Lu YZ; Li LS; Liu ZH
Kidney Int; 2010 Jun; 77(11):974-88. PubMed ID: 20375980
[TBL] [Abstract][Full Text] [Related]
6. Autophagy protects podocytes from sublytic complement induced injury.
Lv Q; Yang F; Chen K; Zhang Y
Exp Cell Res; 2016 Feb; 341(2):132-8. PubMed ID: 26883468
[TBL] [Abstract][Full Text] [Related]
7. Cellular response to injury in membranous nephropathy.
Nangaku M; Shankland SJ; Couser WG
J Am Soc Nephrol; 2005 May; 16(5):1195-204. PubMed ID: 15800119
[TBL] [Abstract][Full Text] [Related]
8. Silencing of CXCL12 performs a protective effect on C5b-9-induced injury in podocytes.
Sha W; Shen L; Zhou L; Xu D; Yang J; Lu G
Int Urol Nephrol; 2018 Aug; 50(8):1535-1544. PubMed ID: 29508174
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of TRPC6 regulates ERK1/2 to prevent sublytic C5b‑9 complement complex‑induced podocyte injury through activating autophagy.
Li Y; Fang Y; Liu J
Exp Ther Med; 2023 Dec; 26(6):576. PubMed ID: 38023364
[TBL] [Abstract][Full Text] [Related]
10. Autophagy-Lysosome Pathway in Renal Tubular Epithelial Cells Is Disrupted by Advanced Glycation End Products in Diabetic Nephropathy.
Liu WJ; Shen TT; Chen RH; Wu HL; Wang YJ; Deng JK; Chen QH; Pan Q; Huang Fu CM; Tao JL; Liang D; Liu HF
J Biol Chem; 2015 Aug; 290(33):20499-510. PubMed ID: 26100632
[TBL] [Abstract][Full Text] [Related]
11. DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes.
Pippin JW; Durvasula R; Petermann A; Hiromura K; Couser WG; Shankland SJ
J Clin Invest; 2003 Mar; 111(6):877-85. PubMed ID: 12639994
[TBL] [Abstract][Full Text] [Related]
12. Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy.
Haddad G; Lorenzen JM; Ma H; de Haan N; Seeger H; Zaghrini C; Brandt S; Kölling M; Wegmann U; Kiss B; Pál G; Gál P; Wüthrich RP; Wuhrer M; Beck LH; Salant DJ; Lambeau G; Kistler AD
J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33351779
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV attenuates complement membranous attack complex induced podocyte injury through the MAPK pathway.
Zheng R; Deng Y; Chen Y; Fan J; Zhang M; Zhong Y; Zhu R; Wang L
Phytother Res; 2012 Jun; 26(6):892-8. PubMed ID: 22086717
[TBL] [Abstract][Full Text] [Related]
14. sPLA2-IB and PLA2R mediate insufficient autophagy and contribute to podocyte injury in idiopathic membranous nephropathy by activation of the p38MAPK/mTOR/ULK1
Yang L; Wu Y; Lin S; Dai B; Chen H; Tao X; Li G; Wan J; Pan Y
FASEB J; 2021 Feb; 35(2):e21170. PubMed ID: 33184968
[TBL] [Abstract][Full Text] [Related]
15. Cellular and molecular biology of membranous nephropathy.
Couser WG; Nangaku M
J Nephrol; 2006; 19(6):699-705. PubMed ID: 17173240
[TBL] [Abstract][Full Text] [Related]
16. Complement-mediated cellular injury.
Takano T; Elimam H; Cybulsky AV
Semin Nephrol; 2013 Nov; 33(6):586-601. PubMed ID: 24161043
[TBL] [Abstract][Full Text] [Related]
17. Membranous nephropathy.
Cybulsky AV
Contrib Nephrol; 2011; 169():107-125. PubMed ID: 21252514
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the Wnt/β-catenin signaling pathway reduces autophagy levels in complement treated podocytes.
Dong Z; Dai H; Gao Y; Feng Z; Liu W; Liu F; Zhang Z; Ma F; Xie X; Zhu Z; Liu W; Liu B
Exp Ther Med; 2021 Jul; 22(1):737. PubMed ID: 34055054
[TBL] [Abstract][Full Text] [Related]
19. Glial cell line-derived neurotrophic factor and its receptor ret is a novel ligand-receptor complex critical for survival response during podocyte injury.
Tsui CC; Shankland SJ; Pierchala BA
J Am Soc Nephrol; 2006 Jun; 17(6):1543-52. PubMed ID: 16672314
[TBL] [Abstract][Full Text] [Related]
20. Podocyte autophagy is associated with foot process effacement and proteinuria in patients with minimal change nephrotic syndrome.
Ogawa-Akiyama A; Sugiyama H; Kitagawa M; Tanaka K; Kano Y; Mise K; Otaka N; Tanabe K; Morinaga H; Kinomura M; Uchida HA; Wada J
PLoS One; 2020; 15(1):e0228337. PubMed ID: 31978139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
